An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

CompletedOBSERVATIONAL
Enrollment

6,458

Participants

Timeline

Start Date

April 11, 2023

Primary Completion Date

May 8, 2025

Study Completion Date

May 8, 2025

Conditions
Postoperative ComplicationsNeuromuscular BlockadeAnesthesia
Interventions
DRUG

Sugammadex

As this is a non-interventional study designed to collect data as part of routine clinical practice, the type and dose of neuromuscular blocking agents are all based on the clinician's judgment.

Trial Locations (1)

02841

Korea University Anam Hospital, Seoul

All Listed Sponsors
lead

Boryung Pharmaceutical Co., Ltd

INDUSTRY